Lipid Nanoparticle-Mediated Delivery of Gene Editing Reagents for Targeted Disruption of Oncogenic Drivers in C-Myc Overexpressing Malignancies (UCLA Case No. 2025-9A9)

Contact UCLA Technology Development Group to learn more.

Download as PDF

For More Information:

Thibault Renac

Business Development Officer

Thibault.Renac@tdg.ucla.edu

Inventors:

Tanya Stoyanova

Categories:

Therapeutics > Gene Therapy And Editing

Therapeutics > Oncology